AGBA Congrats, what a move over a few days.

hL

Good weekend all, Gin n tonics. (lots of lime) :)

That's what I thought. :) Good weekend.

On or about Jan 11, 2024, and Jan 24, 2024, other reorganizational events occurred. In conjunction with a loan default of HIRU relating to the water packing business division the financier exercised their default remedies and sold part of the note in
collection in an off the market private transaction to two separate nonrelated entities.

01/11/2024 New Issuance 260,000,000 Common Red Rock Fund Corp.
01/24/2024 New Issuance 250,000,000 Common GB II., Inc.

Notwithstanding the creditor has legal possession of the water equipment, the water equipment remains in HIRU possession, and the relationship is civil and non-adversary. The Company has agreed with the financier that once the equipment is sold (which value is far greater than the loan amount) any surplus from the sale will be returned to the Company.

https://www.otcmarkets.com/otcapi/company/financial-report/398157/content

These are the Professionals at the $SHMN helm:

In no particular order...They can bring it home, imo.

Mark Stevens, Science Advisor:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174197635
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174136261
https://www.linkedin.com/in/mark-stevens-phd-810167a/

Eddie Chung, Coastar CEO:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174150084
"This marks a thrilling juncture for both companies and the realm of gene editing," stated Eddie Chung, CEO of Coastar. "We're intrigued by the precision and integrase capabilities presented by the ABBIE system. This partnership will yield a novel platform applicable in both laboratory and clinical use."
https://coastartherapeutics.com/about-us/
https://www.globenewswire.com/news-release/2024/04/01/2855240/0/en/SOHM-Inc-and-Coastar-Therapeutics-Sign-MoU-and-Announce-Collaboration-to-Revolutionize-Genome-Editing-Using-Red-Blood-Cell-Membrane-Derived-Carriers.html

Tony Tontat, Strategic Financial Analyst:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173733984
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173582848
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173546689

Alfred Gallegos, SHMN Research Scientist:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173660637
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173660026
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173659156
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Collaborates-with-University-of-Arizona-Center-for-Innovation-to-Advance-ABBIE-a-Groundbreaking-Non-Viral-Gene-Edit?id=416912


Eric Furman, Ph.D. Knobbe Martens Sohm Intellectual Property Attorney:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173289185
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173246026

Wm. Dewey Rushing, VP of Quality Sohm:
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173082914
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173082680
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173031688
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172828177
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172794328
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-as-VP-of-Quality-with-Immediate-Effect?id=413696
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-former-US-FDA-Investigator-to-its-Advisory-Board?id=344969

Dr. Krishna Bhatt, Chief Medical Advisor, Bioscientist and Cardiologist:
Current owner of 82 Million Common shares, and recent Preferred Shares in exchange for Funding.
https://www.otcmarkets.com/otcapi/company/financial-report/396087/content
https://www.biomedwire.com/leadership-changes-at-sohm-inc-shmn-to-strengthen-growth-strategies-for-generic-drug-market-and-gene-editing-platform-development/
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Expands-Its-Advisory-Board-Appointing-Dr-Krishna-Bhat-MD-PhD-FACC-as-Chief-Medical-Advisor?id=411792

Dr. David Aguilar, Sohm Chief Operating Officer:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172703663
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172599661
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announce-the-Appointment-of-Dr-David-Aguilar-PhD-as-a-Chief-Operating-Officer-with-the-Company-with-Immediate-E?id=410079
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Expands-Advisory-Board-with-Appointment-of-Dr-David-Aguilar-PhD-as-its-Expert-Medical-Advisor?id=346149

We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.

The overwhelming interest and impact generated by our innovation have been… pic.twitter.com/50Ggv6hqPj

— SOHM, Inc. (@sohminc) April 9, 2024

Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy

— SOHM, Inc. (@sohminc) March 28, 2024

After a successful visit to Japan, our COO, Dr. David Aguilar is back and here are couple pictures of him working at Carlsbad facility with production in-charge.

Secondly, we are glad to share that we are working with multiple companies for CDMO services and production at the… pic.twitter.com/Wj5qUGgpRe

— SOHM, Inc. (@sohminc) January 25, 2024

We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs

— SOHM, Inc. (@sohminc) December 31, 2023

All good ones. He was a wizzard. Lost him way too early.

Urock will soon be We rock. (RJD)

hL gdvm

Tweet/Link to article on Linkedin:

Discover the 9 trends changing the future of medicine and transforming pharmaceuticals 

Check out: https://t.co/yxIsQnKs5S $SHMN #PharmacyTrends #MedicineTrends pic.twitter.com/J1bVfl6NbA

— SOHM, Inc. (@sohminc) April 15, 2024

Lots of good technical information in this post.

Thank you. hL shmn

:)

Hey Jeff I think she bought them as documented on Twitter:

...but IMO, then she sold them, on Oct 13, 2023, or thereabouts...

There was a single trade that went off on that date for over 20,000,000 shares (ish.)

I'm not sure if anyone else thinks the same, but when it was obvious that everything was unraveling, and Miro was playing hardball around that date, and airing out the laundry on Twitter...IMO that's when she cashed in the chips. Purely imo, no facts to back up my opinion, but if ever there was a court case to find out the facts, I'd be interested to know when the shares went "back to market." I have no idea the ramifications if this happened, haven't researched.

https://www.barchart.com/stocks/quotes/HIRU/technical-chart?plot=CANDLE&volume=total&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=0&indicators=BBANDS(20,2);PTP(50);STOSL(14,3);STOFA(14,3);RSI(14,100);CHKMF(20);CHKMF(10);CHKOSC;ACCUM;OBV;MFI(14,100);SMA(20);SMA(50);MACD(12,26,9);SMA(200)&sym=HIRU&grid=1&height=500&studyheight=200

Respects. hL

He liked your Tweet:

Good to see you out putting in the work unlike other #OTC pinks with someone behind a keyboard all day adding shares. $SHMN

— TraderBill (@1technicaltrade) April 10, 2024

Agree, Apparently "mum's the word" on San Diego.

San Diego entered into a vortex. Update needed. :)

Good to see Stallion Labs facility, and that we're still exclusive distributor for them with LEVETiracetam in the U.S.

"Revenue Outlook: Anticipate substantial revenue growth in the upcoming second quarter and beyond."

hL shmn

LEVETIRACETAM, Excellent!

Introducing SOHM’s Levetiracetam Tablets: Empowering Seizure Control and Freedom.

We are thrilled to unveil SOHM’s Levetiracetam tablets—a high-quality generic alternative meticulously crafted for effective seizure management. These tablets, manufactured by Stallion Laboratories… pic.twitter.com/BSDxwT9pCk

— SOHM, Inc. (@sohminc) April 10, 2024

Thank you to everyone who stopped by to learn more about ABBIE at #AACR2024! It was an honor to showcase our groundbreaking work.
Explore more about ABBIE here: https://t.co/tcmjjGEEW1 

#$SHMN #AACR2024 #coloncancer pic.twitter.com/6ajJVmw3m2

— SOHM, Inc. (@sohminc) April 10, 2024

"We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.

The overwhelming interest and impact generated by our innovation have been truly remarkable.

Stay tuned for more updates following the conclusion of the conference."

Conference Concludes tomorrow the 10th. Should have another update soon. Glad it's going well.

hL shmn

Nice Tweet update on AACR:

We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.

The overwhelming interest and impact generated by our innovation have been… pic.twitter.com/50Ggv6hqPj

— SOHM, Inc. (@sohminc) April 9, 2024

Mark Stevens, Science Advisor at today's AACR Presentation:

Anyone here have such a resume?

Endorsed by various Employees and Colleagues at Merck, Genentech, Astrazeneca, and GlaxoSmithKline.

https://www.linkedin.com/in/mark-stevens-phd-810167a/details/skills/

Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy

— SOHM, Inc. (@sohminc) March 28, 2024

Madguppy, welcome, see below if helpful:

5 days to go! 

We're all set for our big reveal at #AACR2024 that can revolutionize colon cancer treatment.
More: https://t.co/tcmjjGEEW1$SHMN #SOHMInc #CancerResearch #ABBIE #ColonCancer pic.twitter.com/BCuV7f0wvV

— SOHM, Inc. (@sohminc) April 3, 2024

Witness a paradigm shift at #AARC2024 as we unveil our groundbreaking gene-editing platform! It will revolutionize colon cancer treatment.

More: https://t.co/tcmjjGEEW1 pic.twitter.com/I6gqBkOMFA

— SOHM, Inc. (@sohminc) March 25, 2024

Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy

— SOHM, Inc. (@sohminc) March 28, 2024

The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.

This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.

The management remains committed to…

— SOHM, Inc. (@sohminc) March 19, 2024

Intellectual Property Assignment to SOHM, Inc.

SOHM, Inc., a generic pharmaceutical, nutraceutical, cosmeceutical and Biotech firm, had acquired the disruptive stem cell technology and associated patents known as "ABBIE." This acquisition follows a letter of intent signed with…

— SOHM, Inc. (@sohminc) February 29, 2024

We are excited to announce that our company will participate in the American Association for Cancer Research (AACR) annual meeting in San Diego from April 5 to April 10, 2024.

At this internationally attended meeting, we will present our innovative gene-editing system, ABBIE,…

— SOHM, Inc. (@sohminc) February 1, 2024

No prob, all the best to you too knife.

hl

New Corrected Tweet looks like they changed the wording:

I can see why that change needed to be made. :)

5 days to go! 

We're all set for our big reveal at #AACR2024 that can revolutionize colon cancer treatment.
More: https://t.co/tcmjjGEEW1$SHMN #SOHMInc #CancerResearch #ABBIE #ColonCancer pic.twitter.com/BCuV7f0wvV

— SOHM, Inc. (@sohminc) April 3, 2024

Not sure why they deleted, screenshot here:




__
It was a countdown clock for AACR on Monday the 8th.

hL shmn

https://x.com/sohminc/status/1775516437441896865?s=20

"The transaction's closing is contingent upon satisfactory due diligence, definitive agreements and is slated to close by March 31, 2024."

https://www.otcmarkets.com/stock/TDRK/news/Tiderock-Companies-and-MTAG-Composites-to-Merge-to-Create-Global-Materials-Company?id=430884

___
This is all I could find in a brief search about the target date. If someone has more since then in a Tweet or whatever, please post. Maybe they needed a little more time, wouldn't be surprised. Respects all.

Eddie Chung, Coastar CEO: "This marks a thrilling juncture for both companies and the realm of gene editing," stated Eddie Chung, CEO of Coastar. "We're intrigued by the precision and integrase capabilities presented by the ABBIE system. This partnership will yield a novel platform applicable in both laboratory and clinical use."

https://coastartherapeutics.com/about-us/

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

https://www.globenewswire.com/news-release/2024/04/01/2855240/0/en/SOHM-Inc-and-Coastar-Therapeutics-Sign-MoU-and-Announce-Collaboration-to-Revolutionize-Genome-Editing-Using-Red-Blood-Cell-Membrane-Derived-Carriers.html

2023 Annual Report filed:

https://www.otcmarkets.com/stock/SHMN/disclosure

__
hL

I'm pretty sure this is our Mark Stevens:

"Scientist, Pharmacology & Toxicology, Biochemistry; Intellectual Property "

"Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer."

Another University of Arizona guy.
https://www.linkedin.com/in/mark-stevens-phd-810167a/

Impressive Resume, imo. Now also works for US Dept. of Commerce.

Skills include Cancer Research:
https://www.linkedin.com/in/mark-stevens-phd-810167a/details/skills/
https://www.linkedin.com/in/mark-stevens-phd-810167a/details/publications/

You may have mentioned Mark Stevens before? He also has a past U of A background? Thx. $shmn

— Dave (@hardlesson1) March 28, 2024

Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy

— SOHM, Inc. (@sohminc) March 28, 2024

No price predictions from me, but they would have to come up with something pretty compelling for me to care. Of course I'm one small trader so who cares what I think. I do wish they'd stop playing musical chairs for those invested here.

:) With the snap of a finger HIRU is AAA.

Arizona, Austria, Australia. (Projects)

https://mining.otchiru.com/austria-project/

"NEW key mining staff & project announcements will follow as PR & Filings."

___
I can't remember if this is a reincarnation of an old MNGG project, or staff? Serious question if anyone knows.
https://mnggotc.com/

__Just posting info. Good long weekend all. Gin n Tonics if you got 'em.

$HIRU mining division launched. https://t.co/uwN2JGNxwC NEW key mining staff & project announcements will follow as PR & Filings.

— @Hirucorp (@Hirucorpnew) March 28, 2024

To my knowledge, he has only responded to me once, a few months ago. Since then, I didn't feel like going down that rabbit hole.

I've posted responses and questions of others on Twitter X.

Even if I did ask him that question, it seems too late to ask, because the info you posted about the "water biz" being resurrected just got a headstone. Even if he answered, could we trust he, or management, wouldn't change their minds next month?

Seems to me, that Control of direction here now, and in the past, revolves around if money is owed to the "you know who's."

Imo.

You could also add that HIRU said this 5 days ago:

"HIRU also has a well-developed water packaging infrastructure and a second operating water packing division. The water division is
currently in restoration mode." https://www.otcmarkets.com/otcapi/company/financial-report/394913/content

There's also the swarm of swamp sewer surrounding Kathryn and Joel.

I'm pretty sure that neither you or I think that Miro caused Alkaline 88's internal issues going back to before the August 2023 Letter.

To me, that was the Domino that started this chain reaction these past few months.

Although what's happened since then has been________________. (Fill-in-the-blank.)

The antics that I (and others) have posted here by "the parties" have been disgusting, to be honest.

$HIRU has decided to go with the mining deal opportunity. Over the Easter holidays we will be preparing investor deck web site, business plans current revenues and projections on the incoming mining deal which will be filed with OTC & PR.

— @Hirucorp (@Hirucorpnew) March 27, 2024

We are also in final negotiations to sell the water packing division on all cash basis.

— @Hirucorp (@Hirucorpnew) March 27, 2024

"Lets get a little more specific on the HIRU water operation. Are we still producing bottle water? From what location? How many lines do we have left? How is the sales looking?"
https://twitter.com/skies_bluebird/with_replies


"Are you not seeing the filings & Lawsuits? $hiru had 1 customer Alkaline 88 who went bust! Ex mngmt scammed bank $15 mill. What water biz? The only good value left is the logistics biz that s/h dont give a ratsass about and co doing a hailmary play with mining. Its a salvage ops."

___
Follow the thread for today's ____________, imo.

https://t.co/AMZ0aMdIVK

— AI_CPG (AWON) Pink Sheets (@A1Beverages) March 25, 2024

3.25.24: A1 Group Appoints Ruben Padilla as Head, Embarking on a New Era of Leadership

https://www.prnewswire.com/news-releases/a1-group-appoints-ruben-padilla-as-head-embarking-on-a-new-era-of-leadership-302098508.html

"Look we spent $100 lol." :)